Goldshleger Ilya
SEC CIK 1874147 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXST | RxSight, Inc. | See remarks | 81.5K | $33.3K | $8.03M | 55 | 2021-08-05 | 2026-09-02 |
Most active insiders at RXST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilterding Mark | CFO | — | $54.0K |
| 2 | Kurtz Ronald M MD | Chief Medical Off | — | $35.5K |
| 3 | Goldshleger Ilya | See remarks | — | $14.2K |
| 4 | Weinberg Eric | See remarks | — | $14.2K |
| 5 | Gaines Scott | Chief Customer Off | — | — |
| 6 | Fountain Tamara | Dir | — | — |
| 7 | Corley Jesse Anderson | Dir | — | — |
| 8 | Warner Robert Keith | Dir | — | — |
| 9 | Maniar Shweta | Dir | — | — |
| 10 | Andrews Julie | Dir | — | — |
Transactions 55
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-02 21:34 | 2026-08-31 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | — | +5,370 | 83.5K | +7% | — |
| D | 2026-09-02 21:34 | 2026-09-02 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $6.96 | -2,041 | 81.5K | -2% | -$14.2K |
| D | 2026-04-20 16:19 | 2026-04-17 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $4.13 | +12.5K | 78.2K | +19% | +$51.6K |
| DM | 2025-09-26 | 2025-09-25 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $4.27 | +23.4K | 57.3K | +69% | +$100.0K |
| DT | 2024-12-03 | 2024-11-29 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,105 | 45.4K | +7% | +$46.8K |
| DT | 2024-12-03 | 2024-11-29 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $46.08 | -3,105 | 42.2K | -7% | -$143.1K |
| DMT | 2024-11-26 | 2024-11-22+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,200 | 45.3K | +16% | +$93.5K |
| DMT | 2024-11-26 | 2024-11-22+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $45.44 | -6,200 | 42.2K | -13% | -$281.7K |
| DMT | 2024-11-18 | 2024-11-15+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $45.61 | -7,975 | 42.3K | -16% | -$363.8K |
| DMT | 2024-11-18 | 2024-11-15+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +7,975 | 45.3K | +21% | +$120.3K |
| DT | 2024-11-14 | 2024-11-12 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +1,330 | 43.6K | +3% | +$20.1K |
| DT | 2024-11-14 | 2024-11-12 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $46.13 | -1,330 | 42.2K | -3% | -$61.4K |
| DT | 2024-11-08 | 2024-11-07 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,100 | 45.3K | +7% | +$46.7K |
| DMT | 2024-11-08 | 2024-11-07 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $55.00 | -3,100 | 42.2K | -7% | -$170.5K |
| DMT | 2024-11-05 | 2024-11-04 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $51.04 | -3,100 | 42.2K | -7% | -$158.2K |
| DT | 2024-11-05 | 2024-11-04 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,100 | 45.3K | +7% | +$46.7K |
| DT | 2024-10-31 | 2024-10-30 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,105 | 45.4K | +7% | +$46.8K |
| DT | 2024-10-31 | 2024-10-30 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $51.91 | -3,105 | 42.2K | -7% | -$161.2K |
| DMT | 2024-10-28 | 2024-10-25+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $50.22 | -6,200 | 42.2K | -13% | -$311.3K |
| DMT | 2024-10-28 | 2024-10-25+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,200 | 45.3K | +16% | +$93.5K |
| DT | 2024-10-22 | 2024-10-22 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,100 | 45.3K | +7% | +$46.7K |
| DT | 2024-10-22 | 2024-10-22 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.68 | -3,100 | 42.2K | -7% | -$154.0K |
| DMT | 2024-10-18 | 2024-10-16+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.93 | -6,205 | 42.2K | -13% | -$309.8K |
| DMT | 2024-10-18 | 2024-10-16+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,205 | 45.3K | +16% | +$93.6K |
| DMT | 2024-10-15 | 2024-10-10+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.70 | -9,305 | 42.2K | -18% | -$462.5K |
| DMT | 2024-10-15 | 2024-10-10+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +9,305 | 45.4K | +26% | +$140.3K |
| DMT | 2024-10-08 | 2024-10-04+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $48.14 | -6,200 | 42.5K | -13% | -$298.4K |
| DMT | 2024-10-08 | 2024-10-04+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,200 | 45.3K | +16% | +$93.5K |
| DMT | 2024-09-30 | 2024-09-26+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.15 | -6,205 | 43.7K | -12% | -$305.0K |
| DMT | 2024-09-30 | 2024-09-26+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,205 | 45.3K | +16% | +$93.6K |
| DMT | 2024-09-23 | 2024-09-20+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $52.93 | -6,200 | 42.4K | -13% | -$328.1K |
| DMT | 2024-09-23 | 2024-09-20+ | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +6,200 | 45.3K | +16% | +$93.5K |
| DT | 2024-09-18 | 2024-09-17 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $56.11 | -3,100 | 42.2K | -7% | -$173.9K |
| DT | 2024-09-18 | 2024-09-17 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | M - OptEx | $15.08 | +3,100 | 45.3K | +7% | +$46.7K |
| MT | 2024-08-06 | 2024-08-05 | RXST | RxSight, Inc. | Goldshleger Ilya | See remarks | S - Sale | $39.25 | -9,000 | 45.2K | -17% | -$353.3K |
| DM | 2024-05-20 | 2024-05-17 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $4.04 | +24.8K | 42.1K | +143% | +$100.1K |
| DMT | 2024-02-16 | 2024-02-14+ | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $23.04 | +25.0K | 36.5K | +218% | +$576.0K |
| DMT | 2024-02-16 | 2024-02-14+ | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $54.00 | -25.0K | 31.5K | -44% | -$1.35M |
| DMT | 2024-02-12 | 2024-02-09 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $20.90 | +10.4K | 36.8K | +39% | +$216.6K |
| DMT | 2024-02-12 | 2024-02-09 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $50.74 | -10.4K | 31.5K | -25% | -$525.9K |
| DMT | 2024-02-02 | 2024-02-01 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $19.24 | +7,129 | 33.6K | +27% | +$137.2K |
| DMT | 2024-02-02 | 2024-02-01 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $49.29 | -7,129 | 26.5K | -21% | -$351.4K |
| DT | 2024-01-22 | 2024-01-22 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $18.90 | +5,000 | 31.5K | +19% | +$94.5K |
| DT | 2024-01-22 | 2024-01-22 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $48.00 | -5,000 | 26.5K | -16% | -$240.0K |
| DT | 2024-01-10 | 2024-01-09 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $47.00 | -5,000 | 26.5K | -16% | -$235.0K |
| DT | 2024-01-10 | 2024-01-09 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $18.90 | +5,000 | 31.5K | +19% | +$94.5K |
| DMT | 2024-01-09 | 2024-01-08 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $43.33 | -15.0K | 31.5K | -32% | -$650.0K |
| DT | 2024-01-09 | 2024-01-08 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $15.08 | +15.0K | 41.5K | +57% | +$226.2K |
| D | 2023-12-26 | 2023-12-22 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $40.00 | -5,000 | 26.5K | -16% | -$200.0K |
| D | 2023-12-26 | 2023-12-22 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $15.08 | +5,000 | 31.5K | +19% | +$75.4K |
| DM | 2023-12-20 | 2023-12-18 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $39.01 | -10.9K | 31.5K | -26% | -$426.7K |
| DM | 2023-12-20 | 2023-12-18 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $14.14 | +10.9K | 37.4K | +41% | +$154.7K |
| D | 2023-07-27 | 2023-07-26 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | M - OptEx | $3.93 | +25.5K | 26.5K | +2,548% | +$100.1K |
| 2021-08-06 | 2021-08-05 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | P - Purchase | $14.49 | +1,000 | 1,000 | New | +$14.5K | |
| I | 2021-08-06 | 2021-08-05 | RXST | RxSight, Inc. | Goldshleger Ilya | COO | P - Purchase | $13.69 | +1,372 | 1,372 | New | +$18.8K |
Purchase Sale Sale after option exercise All abbreviations